Transforming growth factor‐– and Activin–Smad signaling pathways are activated at distinct maturation stages of the thymopoeisis

Author： Rosendahl Alexander  

Publisher： Oxford University Press

ISSN： 1460-2377

Source： International Immunology, Vol.15, Iss.12, 2003-12, pp. : 1401-1414

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Transforming growth factor-betas: smad signaling and roles in physiopathology

By Javelaud D.   Mauviel A.  

Pathologie Biologie, Vol. 52, Iss. 1, 2004-01 ,pp. : 50-54

Elsevier

Access to resources Recommend Favorite

Transforming Growth Factor-&bgr; Signaling in Motor Neuron Diseases

By  

Current Molecular Medicine, Vol. 11, Iss. 1, 2011-02 ,pp. : 48-56

Bentham Science Publishers

Access to resources Recommend Favorite

Transforming Growth Factor-beta

By Cox D.A.   Maurer T.  

Clinical Immunology, Vol. 83, Iss. 1, 1997-04 ,pp. : 25-30

Academic Press

Access to resources Recommend Favorite

CD40-mediated signaling in monocytic cells: up-regulation of tumor necrosis factor receptor-associated factor mRNAs and activation of mitogen-activated protein kinase signaling pathways

By Pearson L.L.   Castle B.E.   Kehry M.R.  

International Immunology, Vol. 13, Iss. 3, 2001-03 ,pp. : 273-283

Oxford University Press

Access to resources Recommend Favorite

Transforming growth factor-beta: A target for cancer therapy

By Kelly Ronan J.   Morris John C.  

Journal of Immunotoxicology, Vol. 7, Iss. 1, 2010-03 ,pp. : 15-26

Informa Healthcare

Access to resources Recommend Favorite